PubMed
Oral intake of specific bioactive collagen peptides reduces skin wrinkles and improves dermal matrix synthesis
Proksch E, Schunck M, Zague V, et al. Skin Pharmacol Physiol. 2014
Compare
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
Last reviewed . By the PeptIQ team.
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 44% · Mixed 40% · Unfavorable overall 16%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 100–200 mcg · Most common: 100–200 mcg
Reports span 10–1000 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 54% said they felt similar to their last entry, 36% more positive, and 14% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 34 days · Based on 268 repeat reporters
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 47% · Mixed 40% · Unfavorable overall 13%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg
Reports span 0.01–2 mg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 57% said they felt similar to their last entry, 45% more positive, and 17% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 19 days · Based on 355 repeat reporters
Published sources linked on the Collagen Peptides and VIP wiki pages.
PubMed
Proksch E, Schunck M, Zague V, et al. Skin Pharmacol Physiol. 2014
PubMed
García-Coronado JM, Martínez-Olvera L, Elizondo-Omaña RE, et al. Int Orthop. 2019
PubMed
Czajka A, Kania EM, Genovese L, et al. Nutrition research (New York, N.Y.). 2018
PubMed
Krečak I, Babić G, Skelin M. Acta dermatovenerologica Croatica : ADC. 2022
PubMed
Ghatei MA, Takahashi K, Suzuki H, et al. J Cardiovasc Pharmacol. 2003
PubMed
Delgado M, Chorny A, Gonzalez-Rey E, et al. J Leukoc Biol. 2005
PubMed
Delgado M, Ganea D. Amino Acids. 2013
PubMed
Henning RJ, Sawmiller DR. Cardiovascular Research. 2001
PubMed
Vosko AM, Schroeder A, Loh DH, et al. General and Comparative Endocrinology. 2007
PubMed
Kingsbury MA. Current Opinion in Behavioral Sciences. 2015
ClinicalTrials.gov
ClinicalTrials.gov. Clinical trial registry. 2024
PubMed
Delgado M, Pozo D, Ganea D. Pharmacological reviews. 2004
PubMed
Jiang W, Wang H, Li YS, et al. Journal of biomedical science. 2016